AU2292801A - Compositions and methods for treatment of breast cancer - Google Patents

Compositions and methods for treatment of breast cancer

Info

Publication number
AU2292801A
AU2292801A AU22928/01A AU2292801A AU2292801A AU 2292801 A AU2292801 A AU 2292801A AU 22928/01 A AU22928/01 A AU 22928/01A AU 2292801 A AU2292801 A AU 2292801A AU 2292801 A AU2292801 A AU 2292801A
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
breast cancer
breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22928/01A
Inventor
Geoffrey Clark
Joanne Zujewski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2292801A publication Critical patent/AU2292801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU22928/01A 1999-12-22 2000-12-20 Compositions and methods for treatment of breast cancer Abandoned AU2292801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17192899P 1999-12-22 1999-12-22
US60171928 1999-12-22
PCT/US2000/035315 WO2001045740A2 (en) 1999-12-22 2000-12-20 Compositions and methods for treatment of breast cancer

Publications (1)

Publication Number Publication Date
AU2292801A true AU2292801A (en) 2001-07-03

Family

ID=22625677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22928/01A Abandoned AU2292801A (en) 1999-12-22 2000-12-20 Compositions and methods for treatment of breast cancer

Country Status (2)

Country Link
AU (1) AU2292801A (en)
WO (1) WO2001045740A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027839A1 (en) * 2000-02-04 2003-02-06 Palmer Peter Albert Farnesyl protein transferase inhiitors for treating breast cancer
US7342016B2 (en) * 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
CZ307940B6 (en) 2001-02-19 2019-09-04 Novartis Pharma Ag 40-O- (2-hydroxyethyl) rapamycin for therapy use
CN113559222A (en) * 2021-09-14 2021-10-29 临沧宏胜生物科技开发有限公司 Traditional Chinese medicine composition for inhibiting breast cancer cell metastasis and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2315693C (en) * 1997-12-22 2010-11-30 Schering Corporation Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
AU1230100A (en) * 1998-10-29 2000-05-22 Merck & Co., Inc. A method of treating endometriosis

Also Published As

Publication number Publication date
WO2001045740A2 (en) 2001-06-28
WO2001045740A3 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU7994200A (en) Compositions and methods for therapy and diagnosis of prostate cancer
AU2495200A (en) Compositions and methods for the treatment of tumor
AU6147401A (en) Compositions and methods for the treatment of cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2212299A (en) Compositions and methods for the treatment of tumor
AU1980995A (en) Methods and compositions for treatment of breast cancer
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
EP1007535A4 (en) Methods and compositions for diagnosis and treatment of breast cancer
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
PL352931A1 (en) Compositions and uses of et743 for treating cancer
IL145397A0 (en) Compositions and methods for treatment of cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU3177500A (en) Proteins for diagnosis and treatment of breast cancer
PL350863A1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
AU2292801A (en) Compositions and methods for treatment of breast cancer
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU3655097A (en) Brca1 compositions and methods for the diagnosis and treatment of breast cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase